Bioprinting for Organ Transplant Market is projected to reach US$ 2.73 billion by 2031 | Aspect Biosystems Ltd, EnvisionTEC Llc, Ibio Inc, Printivo, Protolabs, Stratasys

The Bioprinting for Organ Transplant Market was valued at US$ 1.05 billion in 2023 and is projected to reach US$ 2.73 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.2% during the forecast period from 2024 to 2031.

DataM Intelligence's Bioprinting on Organ Transplant Market report offers in-depth insights into the latest market trends, potential growth areas, and evolving industry challenges. Focused on delivering practical and strategic intelligence, DataM Intelligence equips businesses with the knowledge they need to make confident, forward-thinking decisions. Through a blend of qualitative and quantitative research approaches, the firm produces detailed reports that support clients in understanding complex market forces, identifying new opportunities, and achieving long-term growth in a rapidly changing global environment.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/bioprinting-on-organ-transplant-market?sg

Bioprinting on Organ Transplant Market Overview:

Biomanufacturing of organs and tissues in vitro is primarily driven by the growing need for organ transplants and the development of reliable tissue models. Bioprinting-commonly referred to as 3D printing is a cutting-edge technique used to fabricate complex tissues and organs such as the liver, skin, and heart. This process involves the layer-by-layer deposition of biomaterials, living cells, and bioactive molecules to construct functional biological structures. The advancement of bioartificial organs through this technology is opening promising new possibilities for future organ transplant solutions.

The global demand for organ transplantation continues to rise, fueled by increasing cases of organ failure and improved success rates of transplant procedures. However, the supply of donor organs remains critically low, resulting in a persistent shortage. In response, 3D bioprinting has emerged as a transformative solution, enabling the creation of functional, patient-specific tissue constructs. By using living cells and biocompatible materials as "bio-inks," this technology can replicate the intricate structures and physiological environments of human tissues through additive manufacturing bringing us closer to addressing the organ shortage crisis.

Bioprinting on Organ Transplant Industry Dynamics:

Rising Demand for Organ Transplants Fueling Bioprinting Market Growth

The growing global need for artificial organs and organ transplantation is one of the key drivers of the bioprinting market for transplant applications. As the prevalence of organ failure continues to rise and the gap between organ supply and demand widens, the healthcare industry is turning toward innovative solutions like bioprinting to address these challenges.

Increased investments in research and rapid advancements in bioprinting technology are further accelerating market expansion. According to data from Transplant.hrsa.gov, a total of 46,632 organ transplants were performed in the United States in 2023, representing an 8.7% increase over 2022 and a 12.7% increase from 2021-the first year to surpass 40,000 transplants. Notably, 39,679 of these transplants came from deceased donors, marking the eleventh consecutive year of record-setting figures in the U.S.

India has also shown considerable progress. As reported by the NIH in February 2024, the country performs between 17,000 and 18,000 solid organ transplants annually ranking third globally after the U.S. and China. Although India still lags behind in terms of transplants per million population (0.65), improvements are evident. The average number of organs transplanted per deceased donor has increased from 2.43 in 2016 to 3.05 in 2022, signaling better utilization of available organs.

These trends underscore the urgent need for alternative organ sources, making 3D bioprinting a promising and potentially transformative solution to meet future transplantation demands.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/bioprinting-on-organ-transplant-market?sg

Strategic Key Players Driving the Bioprinting on Organ Transplant Market: 3D Systems Corporation, Protolabs, Materialise, Stratasys, General Electric Company, Desktop Metal Inc., Aspect Biosystems Ltd., EnvisionTEC Llc., Ibio Inc., and Printivo.

Research Methodology:

The global Bioprinting on Organ Transplant Market report utilizes a thorough research methodology that combines both primary and secondary data sources to deliver a well-rounded market assessment. This structured approach carefully examines a wide range of factors that influence the industry, such as regulatory policies, government initiatives, current market dynamics, competitive landscape, historical trends, and present market standing. It also considers technological advancements, emerging developments across sectors, market fluctuations, future growth potential, possible obstacles, and key strategic challenges encountered by market players.

Segment Covered in the Bioprinting on Organ Transplant Market:

By Process (Inkjet Bioprinting, Laser-Assisted Bioprinting, Extrusion-Based Bioprinting, Acoustic Bioprinting, Magnetic Bioprinting, Vatphotopolymerization-based Bioprinting, Others)

By Bioink (PEG Diacrylate, Nanocellulose, Collagen I, Graphene, Others)

By Cell Type Used (iPS Cells, Mesenchymal Stem Cells, Keratinocytes, Neural Stem Cells, Others)

By End-User (Hospitals, Research and Educational Institutions, Speciality Clinics, Organ Transplantation Centers, Others)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Recent Developments in the Bioprinting for Organ Transplantation Market

✅ September 2022 - 3D Systems Launches Systemic Bio for Advanced Bioprinting in Drug Development
3D Systems announced the creation of Systemic BioTM, a wholly owned subsidiary focused on applying high-precision bioprinting technologies to pharmaceutical research. Leveraging 3D Systems' advanced production-level bioprinting platforms, Systemic Bio aims to develop vascularized organ models using human cells and biomaterials-offering powerful tools for drug discovery and preclinical testing.

✅ October 2023 - CELLINK and Carcinotech Collaborate on 3D Bioprinted Tumor Models
Carcinotech partnered with leading bioprinting firm CELLINK to develop and commercialize protocols for producing 3D bioprinted tumor models. These advanced cancer models-created using cancer cell lines-are intended to improve the accuracy of drug screening and speed up development timelines. The new protocols will be compatible with CELLINK's BIO CELLX system, helping to streamline research and reduce overall R&D costs.

✅ June 2022 - CollPlant Begins Large-Animal Study for 3D Bioprinted Breast Implants
CollPlant, a regenerative medicine company specializing in tissue repair and organ manufacturing, announced the launch of a large-animal study for its novel 3D bioprinted regenerative breast implants. This initiative targets the global breast implant market, valued at approximately US$2.8 billion, and aims to provide safer, bioengineered alternatives to traditional implant options.

Regional Analysis for Bioprinting on Organ Transplant Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Bioprinting on Organ Transplant Market Research Industry:

➠ Who leads the Bioprinting on Organ Transplant industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Bioprinting on Organ Transplant market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Bioprinting on Organ Transplant market growth?

➠ What are the dominant sales and distribution strategies in the Bioprinting on Organ Transplant industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.